Quadrivalent HPV for types 6, 11, 16 and 18
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cervical Cancer
Conditions
Cervical Cancer, Hpv, Warts
Trial Timeline
May 1, 2010 → Dec 14, 2012
NCT ID
NCT01101750About Quadrivalent HPV for types 6, 11, 16 and 18
Quadrivalent HPV for types 6, 11, 16 and 18 is a approved stage product being developed by Merck for Cervical Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01101750. Target conditions include Cervical Cancer, Hpv, Warts.
What happened to similar drugs?
7 of 20 similar drugs in Cervical Cancer were approved
Approved (7) Terminated (0) Active (13)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01101750 | Approved | Completed |
Competing Products
20 competing products in Cervical Cancer